GB0407382D0 - Therapeutic methods and means - Google Patents
Therapeutic methods and meansInfo
- Publication number
- GB0407382D0 GB0407382D0 GB0407382A GB0407382A GB0407382D0 GB 0407382 D0 GB0407382 D0 GB 0407382D0 GB 0407382 A GB0407382 A GB 0407382A GB 0407382 A GB0407382 A GB 0407382A GB 0407382 D0 GB0407382 D0 GB 0407382D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic methods
- therapeutic
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0407382A GB0407382D0 (en) | 2004-03-31 | 2004-03-31 | Therapeutic methods and means |
PCT/GB2005/001273 WO2005095607A2 (en) | 2004-03-31 | 2005-03-31 | ANTI-SENSE OLIGONUCLEOTIDES DIRECTED TOWARDS THE HIV ψ DOMAIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0407382A GB0407382D0 (en) | 2004-03-31 | 2004-03-31 | Therapeutic methods and means |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0407382D0 true GB0407382D0 (en) | 2004-05-05 |
Family
ID=32247646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0407382A Ceased GB0407382D0 (en) | 2004-03-31 | 2004-03-31 | Therapeutic methods and means |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0407382D0 (en) |
WO (1) | WO2005095607A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2620472T5 (en) * | 2006-10-18 | 2020-07-09 | Ionis Pharmaceuticals Inc | Antisense compounds |
WO2008061537A2 (en) * | 2006-11-23 | 2008-05-29 | Querdenker Aps | Oligonucleotides for modulating target rna activity |
EP2673361B1 (en) | 2011-02-08 | 2016-04-13 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
WO2013022967A1 (en) | 2011-08-11 | 2013-02-14 | Isis Pharmaceuticals, Inc. | Gapped oligomeric compounds comprising 5'-modified deoxyribonucleosides in the gap and uses thereof |
EP2839006B1 (en) | 2012-04-20 | 2018-01-03 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleotides and uses thereof |
US9695418B2 (en) | 2012-10-11 | 2017-07-04 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds comprising bicyclic nucleosides and uses thereof |
WO2018058006A1 (en) * | 2016-09-23 | 2018-03-29 | City Of Hope | Oligonucleotides containing 2'-deoxy-2'fluoro-beta-d-arabinose nucleic acid (2'-fana) for treatment and diagnosis of retroviral diseases |
US20210106525A1 (en) * | 2019-10-11 | 2021-04-15 | Massachusetts Institute Of Technology | Formulations for gastrointestinal delivery of oligonucleotides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0012497D0 (en) * | 2000-05-23 | 2000-07-12 | Syngenix Ltd | Antiviral therapy |
-
2004
- 2004-03-31 GB GB0407382A patent/GB0407382D0/en not_active Ceased
-
2005
- 2005-03-31 WO PCT/GB2005/001273 patent/WO2005095607A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005095607A3 (en) | 2006-06-01 |
WO2005095607A2 (en) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182498A0 (en) | Therapeutic furopyrimidines and thienopyrimidines | |
GB0822148D0 (en) | Methods and apparatus | |
GB0415112D0 (en) | Therapeutic device | |
GB0418328D0 (en) | Cancer methods and medicaments | |
IL177155A0 (en) | Therapeutic combinations | |
EP1838288A4 (en) | Therapeutic materials and methods | |
GB0406088D0 (en) | Infusion apparatus and methods | |
EP1737565A4 (en) | Cos-claus configurations and methods | |
GB0406085D0 (en) | Infusion apparatus and methods | |
GB0417481D0 (en) | Combination therapy | |
GB0428180D0 (en) | Combination therapy | |
EP1804703A4 (en) | Cryo-surgical apparatus and methods | |
SG122903A1 (en) | Therapeutic peptides and method | |
GB0308382D0 (en) | Therapeutic methods and means | |
GB0424339D0 (en) | Combination therapy | |
GB0407382D0 (en) | Therapeutic methods and means | |
GB0424552D0 (en) | Methods and means | |
IL185575A0 (en) | Benzoxazocines and their therapeutic use | |
GB0403847D0 (en) | Methods and means | |
GB0419240D0 (en) | Therapeutic device | |
GB0421911D0 (en) | Methods and means | |
GB0327844D0 (en) | Therapeutic methods and means | |
GB0419181D0 (en) | Methods and means | |
GB0427483D0 (en) | Methods and means | |
GB0423658D0 (en) | Methods and means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |